… hypertension-related risk of HF is not irreversible because in randomized clinical trials (RCTs),
antihypertensive drug treatment is … obtained with several antihypertensive drug classes, 3 …

… agents to achieve goal BP (<140/90 mm Hg, or … treatment with two medications if BP is more
than 20/10 mm Hg above goal. In randomized clinical trials, several antihypertensive agents …

… clinical practice, a greater therapeutic impact can be expected by treating patients with those
classes of antihypertensive drugs … of individual compliance to drug treatment has not been …

… Poor compliance and persistence with antihypertensive medications is one likely … efficacy
of drug treatment established through clinical trials and the results observed in clinical practice (…

… the technique for the initiation of blood pressure–lowering therapy in clinical practice and
virtually no recommendations on how it might be used to assess the efficacy of drug treatment. …

… patients with hypertension, BP control rates among treated patients in actual clinical practice
are … often associated with discontinuing antihypertensive drug therapy. Nonpersistence with …

… hypertension, those with diabetes and chronic kidney disease are accepted as being at high
risk and antihypertensive drug therapy … ,8 recommends antihypertensive drug therapy for all …

… the use antihypertensive drug therapy and … the clinical use of combination antihypertensive
therapy and to evaluate the controversial and incorrect combination of antihypertensive drugs …

… for high blood pressure or to their increased blood pressure, 80% (814/1013) in the group
of patients undergoing antihypertensive drug therapy reported at least one symptom. In the …

… a clinical practice-based analysis of how long patients remain on various antihypertensive
drugs… An administrative database listing of patient baseline characteristics, drug prescriptions, …